Cargando…

Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy

Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitum...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiali, Fu, Qiqi, Jiang, Hui, Li, Yinghua, Liu, Muqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606592/
https://www.ncbi.nlm.nih.gov/pubmed/36313662
http://dx.doi.org/10.3389/fonc.2022.1022973
_version_ 1784818330349076480
author Yang, Jiali
Fu, Qiqi
Jiang, Hui
Li, Yinghua
Liu, Muqing
author_facet Yang, Jiali
Fu, Qiqi
Jiang, Hui
Li, Yinghua
Liu, Muqing
author_sort Yang, Jiali
collection PubMed
description Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitumor therapeutic approach including photodynamic therapy (PDT), photothermal therapy (PTT), and photobiomodulation therapy (PBMT), has been widely applied in superficial skin tumor research and clinical treatment. OS is the typical deep tumor, and its phototherapy research faces great limitations and challenges. Surprisingly, pulse mode LED light can effectively improve tissue penetration and reduce skin damage caused by high light intensity and has great application potential in deep tumor research. In this review, we discussed the research progress and related molecular mechanisms of phototherapy in the treatment of OS, mainly summarized the status quo of blue light PBMT in the scientific research and clinical applications of tumor treatment, and outlooked the application prospect of pulsed blue LED light in the treatment of OS, so as to further improve clinical survival rate and prognosis of OS treatment and explore corresponding cellular mechanisms.
format Online
Article
Text
id pubmed-9606592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96065922022-10-28 Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy Yang, Jiali Fu, Qiqi Jiang, Hui Li, Yinghua Liu, Muqing Front Oncol Oncology Osteosarcoma (OS) is the most common primary malignant bone tumor that mainly affects the pediatric and adolescent population; limb salvage treatment has become one of the most concerned and expected outcomes of OS patients recently. Phototherapy (PT), as a novel, non-invasive, and efficient antitumor therapeutic approach including photodynamic therapy (PDT), photothermal therapy (PTT), and photobiomodulation therapy (PBMT), has been widely applied in superficial skin tumor research and clinical treatment. OS is the typical deep tumor, and its phototherapy research faces great limitations and challenges. Surprisingly, pulse mode LED light can effectively improve tissue penetration and reduce skin damage caused by high light intensity and has great application potential in deep tumor research. In this review, we discussed the research progress and related molecular mechanisms of phototherapy in the treatment of OS, mainly summarized the status quo of blue light PBMT in the scientific research and clinical applications of tumor treatment, and outlooked the application prospect of pulsed blue LED light in the treatment of OS, so as to further improve clinical survival rate and prognosis of OS treatment and explore corresponding cellular mechanisms. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606592/ /pubmed/36313662 http://dx.doi.org/10.3389/fonc.2022.1022973 Text en Copyright © 2022 Yang, Fu, Jiang, Li and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Jiali
Fu, Qiqi
Jiang, Hui
Li, Yinghua
Liu, Muqing
Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title_full Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title_fullStr Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title_full_unstemmed Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title_short Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
title_sort progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606592/
https://www.ncbi.nlm.nih.gov/pubmed/36313662
http://dx.doi.org/10.3389/fonc.2022.1022973
work_keys_str_mv AT yangjiali progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy
AT fuqiqi progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy
AT jianghui progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy
AT liyinghua progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy
AT liumuqing progressofphototherapyforosteosarcomaandapplicationprospectofbluelightphotobiomodulationtherapy